-
1Academic Journal
المؤلفون: I. K. Malashenkova, V. L. Ushakov, S. A. Krynskiy, D. P. Ogurtsov, N. A. Khailov, A. Yu. Ratushnyy, E. A. Filippova, N. V. Zakharova, G. P. Kostyuk, N. A. Didkovsky, И. К. Малашенкова, В. Л. Ушаков, С. А. Крынский, Д. П. Огурцов, Н. А. Хайлов, А. Ю. Ратушный, Е. А. Филиппова, Н. В. Захарова, Г. П. Костюк, Н. А. Дидковский
المساهمون: This work was supported by the National Research Center “Kurchatov Institute” (the Thematic Plan for 2023, Order No. 86 dated January 20, 2023, "Applied research in biomedicine, including research in primatology")., Работа выполнена при поддержке Национального исследовательского центра "Курчатовский институт" (пункт 1п.4.3 Темплана на 2023 г., приказ № 86 от 20 января 2023 г.).
المصدر: Medical Immunology (Russia); Том 25, № 5 (2023); 1225-1232 ; Медицинская иммунология; Том 25, № 5 (2023); 1225-1232 ; 2313-741X ; 1563-0625
مصطلحات موضوعية: шизофрения, cytokines, IL-17A, magnetic resonance imaging, mean cortical thickness, schizophrenia, single nucleotide polymorphism, цитокины, IL-17А, магнитная резонансная томография, однонуклеотидный полиморфизм, средняя толщина коры
وصف الملف: application/pdf
Relation: https://www.mimmun.ru/mimmun/article/view/2806/1755; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2806/11778; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2806/11779; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2806/11780; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2806/11782; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2806/11783; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2806/11784; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2806/11785; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2806/11786; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2806/12300; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2806/12301; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2806/12361; Beringer A., Noack M., Mios sec. P. IL-17 in chronic inflammation: from discovery to targeting. Trends Mol. Med., 2016, Vol. 22, pp. 230-241.; Liu Q., Xin W., He P., Turner D., Yin J., Gan Y., Shi F.D., Wu J. Interleukin-17 inhibits adult hippocampal neurogenesis. Sci. Rep., 2014, Vol. 4, 7554. doi:10.1038/srep07554.; Malashenkova I.K., Ushakov V.L., Krynskiy S.A., Ogurtsov D.P., Khailov N.A., Chekulaeva E.I., Filippova E.A., Orlov V.A., Didkovsky N.A., Zakharova N.A., Andreyuk D.S., Kostyuk G.P. Association of structural changes of the brain with systemic immune activation in schizophrenia. Procedia Computer Science, 2022, Vol. 213, pp. 325-331.; Malashenkova I.K., Ushakov V.L., Krynskiy S.A., Ogurtsov D.P., Khailov N.A., Ratushnyy A.Yu, Chekulaeva E.I., Zakharova N.V., Kostyuk G.P., Didkovsky N.A. Association of IL-17A levels with immuneinflammatory profile and structural MRI data in patients with schizophrenia. Medical Immunology (Russia), 2022, Vol. 24, no. 6, pp. 1159-1170. (In Russ.) doi:10.15789/1563-0625-AOI-2528.; McKenna P.J. What works in schizophrenia: cognitive behaviour therapy is not effective. BMJ, 2006, Vol. 333, no. 7563, 353. doi:10.1136/bmj.333.7563.353-a.; McKinney E.F., Cuthbertson I., Harris K.M., Smilek D.E., Connor C., Manferrari G., Carr E.J., Zamvil S.S., Smith K.G.C. A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis. Nat. Commun., 2021, Vol. 12, no. 1, 635. doi:10.1038/s41467-020-20594-2.; Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry, 2011, Vol. 70, no. 7, pp. 663-671.; Rafiei A., Hosseini V., Janbabai G., Ghorbani A., Ajami A., Farzmandfar T., Azizi M.D., Gilbreath J.J., Merrell D.S. Polymorphism in the interleukin-17A promoter contributes to gastric cancer. World J. Gastroenterol., 2013, Vol. 19, no. 34, pp. 5693-5699.; Rajah M.N., Languay R., Grady C.L. Age-related changes in right middle frontal gyrus volume correlate with altered episodic retrieval activity. J. Neurosci., 2011, Vol. 31, no. 49, pp. 17941-17954.; Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., Ransohoff R.M., Greenberg M.E., Barres B.A., Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron, 2012, Vol. 74, no. 4, pp. 691-705.; Stuart M.J., Baune B.T. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies. Neurosci. Biobehav. Rev., 2014, Vol. 42, pp. 93-115.; Takayanagi Y., Sasabayashi D., Takahashi T., Furuichi A., Kido M., Nishikawa Y., Nakamura M., Noguchi K., Suzuki M. Reduced cortical thickness in schizophrenia and schizotypal disorder. Schizophr. Bull., 2020, Vol. 46, no. 2, pp. 387-394.; Ushakov V.L., Malashenkova I.K., Kostyuk G.P., Zakharova N.V., Krynskiy S.A., Kartashov S.I., Ogurtsov D.P., Bravve L.V., Kaydan M.A., Hailov N.A., Chekulaeva E.I., Didkovsky N.A. The Relationship between Inflammation, Cognitive Impairments, and Neuroimaging Data in Schizophrenia. Neurosci. Behav. Physiol., 2021, Vol. 51, no. 7, pp. 873-881.; van Lieshout A.W., van der Voort R., Toonen L.W., van Helden S.F., Figdor C.G., van Riel P.L., Radstake T.R., Adema G.J. Regulation of CXCL16 expression and secretion by myeloid cells is not altered in rheumatoid arthritis. Ann. Rheum. Dis., 2009, Vol. 68, no. 6, pp. 1036-1043.; Wen J., Yu T., Liu L., Hu Z., Yan J., Li Y., Li X. Evaluating the roles of left middle frontal gyrus in word production using electrocorticography. Neurocase, 2017, Vol. 23, no. 5-6, pp. 263-269.; https://www.mimmun.ru/mimmun/article/view/2806
-
2Academic Journal
المؤلفون: I. K. Malashenkova, S. A. Krynskiy, D. P. Ogurtsov, N. A. Khailov, V. D. Melnikova, A. V. Andryushenko, V. B. Savilov, M. V. Kurmyshev, G. P. Kostyuk, N. A. Didkovsky, И. К. Малашенкова, С. А. Крынский, Д. П. Огурцов, Н. А. Хайлов, В. Д. Мельникова, А. В. Андрющенко, В. Б. Савилов, М. В. Курмышев, Г. П. Костюк, Н. А. Дидковский
المساهمون: This work was supported by the National Research Center “Kurchatov Institute” (the Thematic Plan for 2023, Order № 86 dated January 20, 2023, "Applied research in biomedicine, including research in primatology")., Работа выполнена при поддержке Национального исследовательского центра "Курчатовский институт" (пункт 1п.4.3 Темплана на 2023 г., приказ № 86 от 20 января 2023 г.).
المصدر: Medical Immunology (Russia); Том 25, № 5 (2023); 1233-1240 ; Медицинская иммунология; Том 25, № 5 (2023); 1233-1240 ; 2313-741X ; 1563-0625
مصطلحات موضوعية: хемокины, inflammation, mild cognitive impairment, Montreal Cognitive Assessment, rehabilitation, chemokines, воспаление, Монреальская когнитивная шкала, мягкое когнитивное снижение, реабилитация
وصف الملف: application/pdf
Relation: https://www.mimmun.ru/mimmun/article/view/2811/1754; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11804; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11805; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11807; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11808; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11809; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11810; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11811; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11812; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/11813; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/12296; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/12297; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/12298; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/12299; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2811/12367; Bowman G.L., Dayon L., Kirkland R., Wojcik J., Peyratout G., Severin I.C., Henry H., Oikonomidi A., Migliavacca E., Bacher M., Popp J. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults. Alzheimers Dement., 2018, Vol. 14, no. 12, pp. 1640-1650.; Galimberti D., Schoonenboom N., Scheltens P., Fenoglio C., Bouwman F., Venturelli E., Guidi I., Blankenstein M.A., Bresolin N., Scarpini E. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch. Neurol., 2006, Vol. 63, no. 4, pp. 538-543.; Guldner I.H., Wang Q., Yang L., Golomb S.M., Zhao Z., Lopez J.A., Brunory A., Howe E.N., Zhang Y., Palakurthi B., Barron M., Gao H., Xuei X., Liu Y., Li J., Chen D.Z., Landreth G.E., Zhang S. CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10. Cell, 2020, Vol. 183, no. 5, pp. 1234-1248.e25.; Huang Y., Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell, 2012, Vol. 148, no. 6, pp. 1204-1222.; Jang D.I., Lee A.H., Shin H.Y., Song H.R., Park J.H., Kang T.B., Lee S.R., Yang S.H. The Role of Tumor Necrosis Factor Alpha (TNF-a) in autoimmune disease and current TNF-a inhibitors in therapeutics. Int. J. Mol. Sci., 2021, Vol. 22, no. 5, 2719. doi:10.3390/ijms22052719.; Jorda A., Aldasoro M., Aldasoro C., Valles S.L. Inflammatory chemokines expression variations and their receptors in APP/PS1 Mice. J. Alzheimers Dis., 2021, Vol. 83, no. 3, pp. 1051-1060.; Jorda A., Campos-Campos J., Iradi A., Aldasoro M., Aldasoro C., Vila J.M., Valles S.L. The role of chemokines in Alzheimer's Disease. Endocr. Metab. Immune Disord. Drug Targets, 2020, Vol. 20, no. 9, pp. 1383-1390.; Jorda A., Cauli O., Santonja J.M., Aldasoro M., Aldasoro C., Obrador E., Vila J.M., Mauricio M.D., Iradi A., Guerra-Ojeda S., Marchio P., Valles S.L. Changes in chemokines and chemokine receptors expression in a mouse model of Alzheimer's disease. Int. J. Biol. Sci., 2019, Vol. 15, no. 2, pp. 453-463.; Koper O.M., Kaminska J., Sawicki K., Kemona H. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration. Adv. Clin. Exp. Med., 2018, Vol. 27, no. 6, pp. 849-856.; Malashenkova I.K., Krynskiy S.A., Hailov N.A., Ogurtsov D.P., Chekulaeva E.I., Ponomareva E.V., Gavrilova S.I., Didkovsky N.A. Immunological variants of amnestic mild cognitive impairment. S. Korsakov Journal of Neurology and Psychiatry, 2020, Vol. 120, no. 10, pp. 60-68. (In Russ.); Moussa C., Hebron M., Huang X., Ahn J., Rissman R.A., Aisen P.S., Turner R.S. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease. J. Neuroinflammation, 2017, Vol. 14, no. 1, 1. doi:10.1186/s12974-016-0779-0.; Ramesh G., MacLean A.G., Philipp M.T. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm., 2013, Vol. 2013, 480739. doi:10.1155/2013/480739.; Roshchina I.F., Syunyakov T.S., Osipova N.G., Kurmyshev M.V., Savilov V.B., Andruchsenko A.V. Evaluation of the effectiveness of neurocognitive rehabilitation of patients with mild cognitive decline under restrictions during the COVID-19 pandemic. Psychiatry, 2022, Vol. 20, no. 4, pp. 36-43. (In Russ.); Serbina N.V., Shi C., Pamer E.G. Monocyte-mediated immune defense against murine Listeria monocytogenes infection. Adv. Immunol., 2012, Vol. 113, pp. 119-134.; Trollor J.N., Smith E., Baune B.T., Kochan N.A., Campbell L., Samaras K., Crawford J., Brodaty H., Sachdev P. Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study. Dement. Geriatr. Cogn. Disord., 2010, Vol. 30, no. 6, pp. 569-578.; https://www.mimmun.ru/mimmun/article/view/2811
-
3Academic Journal
المؤلفون: I. K. Malashenkova, V. L. Ushakov, S. A. Krynskiy, D. P. Ogurtsov, N. A. Khailov, A. Yu. Ratushnyy, E. I. Chekulaeva, N. V. Zakharova, G. P. Kostyuk, N. A. Didkovsky, И. К. Малашенкова, В. Л. Ушаков, С. А. Крынский, Д. П. Огурцов, Н. А. Хайлов, А. Ю. Ратушный, Е. И. Чекулаева, Н. В. Захарова, Г. П. Костюк, Н. А. Дидковский
المساهمون: Работа выполнена при поддержке Национального исследовательского центра «Курчатовский институт» (подпункт 1.8 «Разработка основ инновационных биомедицинских технологий диагностики и терапии ряда социально значимых заболеваний» пункта 1Ф.I Тематического плана НИОКР на 2022 г.) и частично при поддержке РНФ (грант № 20-15-00299)
المصدر: Medical Immunology (Russia); Том 24, № 6 (2022); 1159-1170 ; Медицинская иммунология; Том 24, № 6 (2022); 1159-1170 ; 2313-741X ; 1563-0625
مصطلحات موضوعية: шизофрения, cortical thickness, inflammation, interleukin-17A, magnetic resonance imaging, schizophrenia, интерлейкин-17А, магнитная резонансная томография, средняя толщина коры, цитокины
وصف الملف: application/pdf
Relation: https://www.mimmun.ru/mimmun/article/view/2528/1611; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9601; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9602; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9603; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9604; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9605; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9606; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9607; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9608; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9609; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9610; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9611; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2528/9612; Bedoya S.K., Lam B., Lau K., Larkin J.3rd. Th17 cells in immunity and autoimmunity. Clin. Dev. Immunol., 2013, Vol. 2013, 986789. doi:10.1155/2013/986789.; Beurel E., Lowell J.A. Th17 cells in depression. Brain Behav. Immun., 2018, Vol. 69, pp. 28-34.; Bogerts B. The temporolimbic system theory of positive schizophrenic symptoms. Schizophr. Bull., 1997, Vol. 23, no. 3, pp. 423-435.; Borovcanin M.M., Minic Janicijevic S., Jovanovic I.P., Gajovic N.M., Jurisevic M.M., Arsenijevic N.N. Type 17 Immune response facilitates progression of inflammation and correlates with cognition in stable schizophrenia. Diagnostics (Basel), 2020, Vol. 10, no. 11, 926. doi:10.3390/diagnostics10110926.; Chen J., Liu X., Zhong Y. Interleukin-17A: The key cytokine in neurodegenerative diseases. Front. Aging Neurosci., 2020, Vol. 12, 566922. doi:10.3389/fnagi.2020.566922.; Chenniappan R., Nandeesha H., Kattimani S., Nanjaiah N.D. Interleukin-17 and Interleukin-10 association with disease progression in schizophrenia. Ann. Neurosci., 2020, Vol. 27, no. 1, pp. 24-28.; Cipollini V., Anrather J., Orzi F., Iadecola C. Th17 and cognitive impairment: possible mechanisms of action. Front. Neuroanat., Vol. 2019, no. 13, 95. doi:10.3389/fnana.2019.00095.; Corsi-Zuelli F.M.D.G., Brognara F., Quirino G.F.D.S., Hiroki C.H., Fais R.S., Del-Ben C.M., Ulloa L., Salgado H.C., Kanashiro A., Loureiro C.M. Neuroimmune interactions in schizophrenia: focus on vagus nerve stimulation and activation of the Alpha-7 nicotinic acetylcholine receptor. Front. Immunol., 2017, Vol. 8, 618. doi:10.3389/fimmu.2017.00618.; de Witte L.D., van Mierlo H.C., Litjens M., Klein H.C., Bahn S., Osterhaus A. D., and GROUP Investigators. The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study. NPJ Schizophr., 2015, Vol. 1, 15041. doi:10.1038/npjschz.2015.41.; Eftekharian M.M., Omrani M.D., Arsang-Jang S., Taheri M., Ghafouri-Fard S. Serum cytokine profile in schizophrenic patients. Hum. Antibodies, 2019, Vol. 27, no. 1, pp. 23-29.; El Kissi Y., Samoud S., Mtiraoui A., Letaief L., Hannachi N., Ayachi M., Ali B., Boukadida J. Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia. Psychiatry Res., 2015, Vol. 225, no. 1-2, pp. 58-63.; Goldsmith D.R., Rapaport M.H., Miller B.J. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol. Psychiatry., 2016, Vol. 21, no. 12, pp. 1696-1709.; International Schizophrenia Consortium, Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O’Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 2009, Vol. 460, no. 7256, pp. 748-752.; Kaladjian A., Belzeaux R., Adida M., Azorin J.M. Negative symptoms and cerebral imaging. Encephale, 2015, Vol. 4, no. 6, Suppl 1, pp. 6S22-6S26.; Koike S., Sakakibara E., Satomura Y., Sakurada H., Yamagishi M., Matsuoka J., Okada N., Kasai K. Shared functional impairment in the prefrontal cortex affects symptom severity across psychiatric disorders. Psychol. Med., 2020, Vol. 18, pp. 1-10.; Liu Q., Xin W., He P., Turner D., Yin J., Gan Y., Shi F.D., Wu J. Interleukin-17 inhibits adult hippocampal neurogenesis. Sci. Rep., 2014, Vol. 4, 7554. doi:10.1038/srep07554.; Malashenkova I.K., Krynskiy S.A., Ogurtsov D.P., Mamoshina M.V., Zakharova N.V., Ushakov V.L., Velichkovsky B.M., Didkovsky N.A. A role of the immune system in the pathogenesis of schizophrenia. S. Korsakov Journal of Neurology and Psychiatry, 2018, Vol. 118, no. 12, pp. 72-80. [In Russ.]; Malashenkova I.K., Ushakov V.L., Krynskiy S.A., Ogurtsov D.P., Khailov N.A., Zakharova N.V., Chekulaeva E.I., Orlov V.A., Kartashov S.I., Andreyuk D.S., Didkovsky N.A., Kostyuk G.P. The relationship of morphometric changes of the brain with IL-6 levels, systemic inflammation and immune disturbances in the patients with schizophrenia. Procedia Computer Science, 2021, Vol. 190, pp. 553-559.; Malashenkova I.K., Ushakov V.L., Zakharova N.V., Krynskiy S.A., Ogurtsov D.P., Hailov N.A., Chekulaeva E.I., Ratushnyy A.Y., Kartashov S.I., Kostyuk G.P., Didkovsky N.A. Neuro-immune aspects of schizophrenia with severe negative symptoms: new diagnostic markers of disease phenotype. Modern Technologies in Medicine, 2021, Vol. 13, no. 6, pp. 24-33.; McKenna P.J. What works in schizophrenia: cognitive behaviour therapy is not effective. BMJ, 2006, Vol. 333, no. 7563, 353. doi:10.1136/bmj.333.7563.353-a.; Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry, 2011, Vol. 70, no. 7, pp. 663-671.; Nazli Ş.B., Koçak O.M., Kirkici B., Sevındık M., Kokurcan A. Investigation of the processing of noun and verb words with fMRI in patients with schizophrenia. Noro Psikiyatr. Ars., 2019, Vol. 57, no. 1, pp. 9-14.; Neugebauer K., Hammans C., Wensing T., Kumar V., Grodd W., Mevissen L., Sternkopf M.A., Novakovic A., Abel T., Habel U., Nickl-Jockschat T. Nerve growth factor serum levels are associated with regional gray matter volume differences in schizophrenia patients. Front. Psychiatry, 2019, Vol. 10, 275. doi:10.3389/fpsyt.2019.00275.; Potvin S., Stip E., Sepehry A.A., Gendron A., Bah R., Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry, 2008, Vol. 63, no. 8, pp. 801-808.; Ruzzo E.K., Geschwind D.H. Schizophrenia genetics complements its mechanistic understanding. Nat Neurosci., 2016, Vol. 19, no. 4, pp. 523-525.; Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., Ransohoff R.M., Greenberg M.E., Barres B.A., Stevens B. Microglia sculpt postnatal neural circuits in an activity and complementdependent manner. Neuron, 2012, Vol. 74, no. 4, pp. 691-705.; Schizophrenia Psychiatric Genome-Wide Association Study Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet., 2011, Vol. 43, no. 10, pp. 969-976.; Sekar A., Bialas A.R., de Rivera H., Davis A., Hammond T.R., Kamitaki N., Tooley K., Presumey J., Baum M., van Doren V., Genovese G., Rose S.A., Handsaker R.E., Schizophrenia Working Group of the Psychiatric Genomics Consortium, Daly M.J., Carroll M.C., Stevens B., McCarroll S.A. Schizophrenia risk from complex variation of complement component 4. Nature, 2016, Vol. 530, no. 7589, pp. 177-183.; Steines M., Nagels A., Kircher T., Straube B. The role of the left and right inferior frontal gyrus in processing metaphoric and unrelated co-speech gestures. Neuroimage, 2021, Vol. 15, no. 237, 118182. doi:10.1016/j.neuroimage.2021.118182.; Takayanagi Y., Sasabayashi D., Takahashi T., Furuichi A., Kido M., Nishikawa Y., Nakamura M., Noguchi K., Suzuki M. Reduced cortical thickness in schizophrenia and schizotypal disorder. Schizophr. Bull., 2020, Vol. 46, no. 2, pp. 387-394.; Rostami A., Ciric B. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. J. Neurol. Sci., 2013, Vol. 333, no. 1-2, pp. 76-87.; Waisman A., Hauptmann J., Regen T. The role of IL-17 in CNS diseases. Acta Neuropathol., 2015, Vol. 129, no. 5, pp. 625-637.; https://www.mimmun.ru/mimmun/article/view/2528